Prephase rituximab/prednisone therapy and aging-related, proinflammatory cytokine milieu in older, vulnerable patients with newly diagnosed diffuse large B-cell lymphoma

Diffuse large B-cell lymphoma (DLBCL) predominantly affects older adults with suboptimal therapeutic outcomes due to increased treatment-related mortality and toxicities in vulnerable patients, clinically defined by geriatric impairments such as functional limitation, multimorbidity, or cognitive de...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Richard J., Owens, Colette N., Drill, Esther, Iannotta, Augustine, Oliveros, Mayan, Schick, Dylan L., Noy, Ariela, Gerecitano, John F., Drullinsky, Pamela R., Caron, Philip C., Kumar, Anita, Matasar, Matthew J., Moskowitz, Craig, Korc-Grodzicki, Beatriz, Zelenetz, Andrew D., Salles, Gilles A., Hamlin, Paul A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052931/
https://www.ncbi.nlm.nih.gov/pubmed/34289656
http://dx.doi.org/10.3324/haematol.2021.278719

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052931/
https://www.ncbi.nlm.nih.gov/pubmed/34289656
http://dx.doi.org/10.3324/haematol.2021.278719

Ejemplares similares